UBS Group’s Pasithea Therapeutics KTTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4K | Buy |
|
|||||
|
2025
Q1 | $5.64K | Sell |
|
|||||
|
2024
Q4 | $40.5K | Buy |
|
|||||
|
2024
Q3 | $35.6K | Buy |
|
|||||
|
2024
Q2 | $192 | Sell |
|
|||||
|
2024
Q1 | $4.41K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $40 | Sell |
|
|||||
|
2023
Q2 | $3.39K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $8.15K | Buy |
|
|||||
|
2022
Q3 | $7K | Sell |
|
|||||
|
2022
Q2 | $13K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $10K | Buy |
|